SRC Stock Recent News

Toronto, Ontario--(Newsfile Corp. - September 3, 2025) - Stakeholder Gold Corp. (TSXV: SRC) (OTC Pink: SKHRF) (WKN: A2QEP1) ("Stakeholder" or the "Company") is pleased to report a gross margin of 76.9% on quartzite sales of $911,837 CAD in H1.2025. Revenues increased by 153% over the year from $359,908 CAD in H1.2024 to $911,837 CAD in H1.2025, and by 38% on the quarter from $383,911 CAD in Q1.2025 to $527,926 CAD in Q2.2025.

Toronto, Ontario--(Newsfile Corp. - August 18, 2025) - Stakeholder Gold Corp. (TSXV: SRC) (OTC Pink: SKHRF) ("Stakeholder" or the "Company") is pleased to celebrate Klondike Gold Discovery Day. Discovery Day has been a statutory holiday in the Yukon Territory since 1911 and falls on the third Monday of August each year.

Toronto, Ontario--(Newsfile Corp. - July 15, 2025) - Stakeholder Gold Corp. (TSXV: SRC) (OTC Pink: SKHRF) ("Stakeholder" or the "Company") is pleased to announce that the Company has initiated it's 2025 exploration program on the Ballarat Gold-Copper Project located in the heart of the White Gold District of the Yukon Territory, Canada. The exploration program this year will include maiden diamond drilling on both the Skye Gold Zone and the Loki Copper Zone targets.

Toronto, Ontario--(Newsfile Corp. - May 1, 2025) - Stakeholder Gold Corp. (TSXV: SRC) (OTC Pink: SKHRF) ("Stakeholder" or the "Company") is pleased to provide an update on sales of exotic Blue Quartzites in Brazil, and to announce export to Canada of the Company's first shipping container carrying White Quartzite slabs (see Figure 1). White Quartzites are produced at the Company's third quarry which is now operational in Brazil.

– SRC recommended that the trial escalate to the next dose level of 30mg capsule – – No dose-limiting toxicities (DLT's) or rash observed to date – MIAMI, April 10, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type 1 (NF1) and other cancer indications, today announced that the external Safety Review Committee recommended that the Company's Phase 1 clinical trial of PAS-004 in advanced cancer should proceed to Cohort 6, 30mg capsule, without modification. This recommendation was based on the review of the safety data from three patients from Cohort 5 and the absence of any dose limiting toxicities (DLT's).

Toronto, Ontario--(Newsfile Corp. - March 11, 2025) - Stakeholder Gold Corp. (TSXV: SRC) (OTC Pink: SKHRF)  ("Stakeholder" or the "Company") is pleased to announce that the Company has submitted a Class 1 Notification for 2025 exploration on the Ballarat Gold-Copper Project; including maiden drilling on the Skye Gold Zone and the Loki Copper Zone. Ballarat Exploration Program 2025 The Company is planning to drill 2,500 meters over 8 - 10 drill holes targeting two previously identified and documented zones of mineralization, the Skye Gold Zone and the Loki Copper Zone.

Toronto, Ontario--(Newsfile Corp. - February 13, 2025) - Stakeholder Gold Corp. (TSXV: SRC) (OTC Pink: SKHRF) ("Stakeholder" or the "Company") is pleased to announce first sales from the Company's third quarry in Minas Gerais, Brazil. The quarry produces white quartzite blocks for cutting and polishing into slabs.

Pasithea's PAS-004 Phase 1 trial advances to 22mg dose with no DLTs or rash, reinforcing its safety profile as a next-gen MEK inhibitor for NF1 and cancer.

Toronto, Ontario--(Newsfile Corp. - January 21, 2025) - Stakeholder Gold Corp. (TSXV: SRC) ("Stakeholder" or the "Company") is pleased to announce results and interpretation for the VLF-EM (Very Low Frequency - Electro-Magnetic) geophysical survey undertaken on the Company's 100% owned Ballarat Gold-Copper Project ("Ballarat") which covers 18,741 Ha in the Heart of the White Gold District of the Yukon Territory, Canada. The VLF-EM survey was a portion of the 2024 summer exploration program on Ballarat.

Since our last analysis, Realty Income has delivered a 17.2% return and completed its merger with Spirit Realty Capital. As the interest rate environment transitions to a rate-cutting cycle, the company's growth prospects are on the rise. DCF analysis shows conservative growth estimates, factoring in historical growth rates and recent mergers, with AFFO providing a clear view of sustainable earnings.